HEC585
HEC585-IPF-301
Phase 3 small_molecule active
Quick answer
HEC585 for Idiopathic Pulmonary Fibrosis (IPF) is a Phase 3 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Idiopathic Pulmonary Fibrosis (IPF)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active